173.413.2
KR-PATGERFP-TFBSPG-TFB
CH
CH
Art. 9 Reglement vom 28. September 2011 über die Prozesskosten beim Bundespatentgericht (KR-PatGer) - Rechtsvertretung durch Patentanwältinnen oder Patentanwälte
KR-PatGer
Art. 9 KR-PatGer · Rechtsvertretung durch Patentanwältinnen oder Patentanwälte
Treten Patentanwältinnen oder Patentanwälte nach Artikel 29 Absatz 1 PatGG als Parteivertreterinnen beziehungsweise Parteivertreter auf, so wird ihre Entschädigung sinngemäss nach Artikel 3 Buchstabe b bemessen.
Sind Patentanwältinnen oder Patentanwälte lediglich beratend tätig, so sind deren Aufwendungen als notwendige Auslagen im Sinne von Artikel 3 Buchstabe a geltend zu machen.
Gerichtsentscheide zu dieser Bestimmung (27)
O2018-008 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
Tiotropium Capsule Patent Invalid for Lack of Inventive Step
Used to determine the amount of the party compensation for legal representation.
O2020-013 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
Federal Patent Court Rules on Costs and Compensation After Moot Infringement Claim
Applied to determine the amount of the compensation for patent attorney fees.
O2019-003 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
European Patent for Intraocular Lens Injector Cartridge Invalidated for Added Matter
Basis for determining the compensation for patent attorney costs.
O2017-012 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
Patent Invalidated for Impermissible Amendments Regarding Pharmaceutical Preparation
This provision is used to determine the reduced amount for necessary expenses.
O2017-013 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
Oxycodone/Naloxone Patent Invalidated Due to Improper Amendment
Used to determine a reduced amount for necessary patent attorney expenses.
O2017-009 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
Invalidation of European Patents for Unallowable Amendments
Cited for the reimbursement of necessary patent attorney fees as part of the party compensation.
O2017-023 (Art. 9 Abs. 2 KR-PatGer)
Patent Holder's SPC Covers Different Salt Forms of Active Ingredient
Cited in the dispositive to determine the compensation for patent attorney advice.
S2018-002 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
Patent Infringement Provisional Measures Denied Due to Lack of Urgency and Proof
Basis for not allowing reimbursement of certain expenses incurred by the defendant.
S2018-001 (Art. 9 Abs. 2 i.V.m. Art. 3 lit. a KR-PatGer)
Patent Infringement Claim Dismissed for Lack of Evidence and Overly Broad Discovery Request
This article pertains to the compensation for patent attorneys and was used to set the appropriate amount.
S2017-006 (Art. 9 Abs. 2 KR-PatGer)
Patent Holder Obtains Preliminary Injunction Against Generic Drug Manufacturer Based on SPC
Cited in the dispositive for the determination of party compensation.
O2017-001 (Art. 9 Abs. 2 KR-PatGer)
Validity of Supplementary Protection Certificate for Combination Drug Under Swiss Law
Cited to explain the conditions under which patent attorney costs can be claimed as necessary expenses, and to deny such expenses to the defendant in this specific case due to lack of substantiation.
S2016-004 (Art. 3, 4, 5, 6 und 9 Abs. 2 KR-PatGer)
Patent Holder Denied Injunction Over Cancer Drug Salt Form Equivalence
These articles are cited in relation to the calculation and awarding of party compensation.
O2014-002 (Art. 9 Abs. 2 KR-PatGer)
Urinal Valve Patent Infringement and Injunction
Cited in the reasoning section in conjunction with Art. 3 KR-PatGer to determine the reasonableness of the patent attorney's fees.
O2012-043 (Art. 9 Abs. 2 in Verbindung mit Art. 3 lit. a KR-PatGer)
Patent for Rail Vehicle Drive System Invalidated Due to Prior Public Disclosure
Necessary expenses, including patent attorney fees, are part of party compensation.
O2015-007 (Art. 3 lit. a und b i.V.m. Art. 5 und Art. 9 Abs. 2 KR-PatGer)
Patent Invalidated for Lack of Priority and Anticipation by Prior Art
The defendant is ordered to pay a party compensation to the plaintiff.